Rybelsus (semaglutide) is a brand-name oral tablet prescribed for type 2 diabetes. As with other drugs, Rybelsus can cause side effects, such as nausea, vomiting, and constipation. Read on to ...

Rybelsus is an oral tablet best taken on an empty stomach. Avoiding certain types of food in your diet may help manage blood sugar levels and minimize certain side effects of the drug. Limiting ...

The FDA approval last Friday of Novo Nordisk’s Rybelsus as the first orally-active GLP-1 agonist is only the first challenge facing the company as it pursues its blockbuster sales targets for ...

Rybelsus and Ozempic are brand-name medications with the same active ingredient: semaglutide. Semaglutide, a GLP-1 agonist, ...

Rybelsus (semaglutide) is a brand-name prescription medication that doctors prescribe alongside exercise and diet to help improve blood sugar levels in adults with type 2 diabetes. Plans often ...

The firm, which already factored in a 50% net price cut for the majority of these drugs in the Medicare Part D channel, most notably Ozempic and Rybelsus, adds that it assumes no Part D sales ...

Rybelsus is a glucagon-like peptide-1 (GLP-1) agonist available as a tablet. It is used to treat type 2 diabetes. Metformin ...